相关实验视频

Updated: Feb 24, 2026

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

对瘤微环境激活的差异化和转移抑制的低氧反应性视网状脂质体

Chunlin Li¹, Di Liu¹, Xiaojie Li¹

¹Department of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, China.

Molecular pharmaceutics

|February 23, 2026

概括

这项研究开发了一种对缺氧反应敏捷的脂质体,可提供全转录氨酸 (ATRA) 以向癌症干细胞 (CSC). 这一策略增强了CSC的分化,并提高了化疗对乳腺癌的有效性.

科学领域:

生物医学工程生物医学工程
药物运输药物运输药物运输
癌症研究癌症研究

背景情况:

癌症干细胞 (CSCs) 驱动瘤异质性,转移和化学抵抗.
全跨网红酸 (ATRA) 可以诱导CSC分化,但由于目标和生物分布不佳,它面临临临床翻译挑战.
需要有效的策略来准CSC并克服转移性乳腺癌中的化学抵抗.

研究的目的:

开发一种对缺氧反应的ATRA-脂合物 (RAPC) 用于向传递和CSC的差异化初始化.
创建具有高药物负载和微环境激活释放的ATRA载脂体 (ATRA@Lip).
评估缺氧触发的ATRA@Lip在促进CSC分化和增强乳腺癌中化学敏感性的疗效.

主要方法:

合成了RAPC,使用基于亚博的低氧可切割连接器在ATRA和酸丁胆类似物之间.
通过RAPC,胆固醇和脂的联合组装制造出稳定的ATRA@Lip,实现高药物负荷 (17重 %).
在正常和低毒条件下评估ATRA释放,并在体外评估CSC分化和化学敏感性.

主要成果:

ATRA@Lip在正常氧气下表现出最小的ATRA泄漏,但由于键裂变而在低氧气下迅速释放.
低氧触发的ATRA@Lip有效地促进了乳腺癌细胞中的CSC分化.
观察到乳腺癌细胞对与白蛋白结合的帕克利塔塞尔 (Nab-PTX) 的化学敏感性增加.

结论:

低氧反应的RAPC平台能够有效地提供ATRA和微环境激活释放.
这一策略有助于CSC初始化,并改善转移性乳腺癌的组合化疗.
开发的脂质体系统提供了一个有前途的方法来调节CSC相关的化学阻力.

关键词:

癌症治疗疗法癌症治疗有控制释放的释放.药物输送是药物输送的过程.药物耐药性耐药性药物耐药性脂药物联合体脂药物联合体

更多相关视频

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

Published on: October 3, 2011

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...